Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 8 November 2005
Vol. 2005, Issue 309, p. tw398
[DOI: 10.1126/stke.3092005tw398]

EDITORS' CHOICE

IMMUNOLOGY Breakdown to Recovery

Regulation of immune responses through local catabolic depletion of tryptophan (Trp) was first identified in studies of the maternal T cell response to the fetus. This pathway, which is controlled by the enzyme indoleamine 2,3-dioxygenase (IDO), has since been identified in a variety of immunological settings. Platten et al. now find that IDO-mediated Trp catabolism also contributes during therapy of a mouse model of multiple sclerosis. By using a form of antigen termed an altered peptide ligand, T cell responses were prevented from causing inflammation and nervous system pathology, and this effect corresponded with the induction of IDO. Naturally occurring metabolites and a synthetic derivative of the IDO pathway inhibited T cell proliferation and activation of antigen-presenting cells. Remarkably, paralyzed mice recovered after being fed the synthetic derivative.

M. Platten, P. P. Ho, S. Youssef, P. Fontoura, H. Garren, E. M. Hur, R. Gupta, L. Y. Lee, B. A. Kidd, W. H. Robinson, R. A. Sobel, M. L. Selley, L. Steinman, Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite. Science 310, 850-855 (2005). [Abstract] [Full Text]

Citation: Breakdown to Recovery. Sci. STKE 2005, tw398 (2005).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882